Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Home/The Filing Wire/Insight Molecular Diagnostics Inc./ 4

SEC Filing · 4

Insight Molecular Diagnostics Inc.

IMDXNASDAQEQUITYCurrent

SEC Filing

Filed Jun 15, 2026Accepted Jun 15, 2026, 6:22 PM EDTCIK 1642380Accession 0001493152-26-028755
View company →Permanent SEC source ↗
Share

Company context

Current securities

IMDXNASDAQ · EQUITY · Current

Recent company filings

  1. Entry into a Material Definitive AgreementSep 21, 2026
  2. 10-Q filingAug 10, 2026
  3. Results of Operations and Financial Condition · Regulation FD Disclosure · Other EventsAug 10, 2026
  4. S-8 filingJul 24, 2026
  5. 4 filingJul 6, 2026

Document unavailable

This filing is not currently available in the archive. Read it on SEC EDGAR ↗